LQDA
Liquidia Technologies IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$3.29B
P/E Ratio
—
EPS
$-0.79
Beta
0.46
52W High
$46.67
52W Low
$11.85
50-Day MA
$37.43
200-Day MA
$28.46
Dividend Yield
—
Profit Margin
-43.50%
Forward P/E
29.67
PEG Ratio
—
About Liquidia Technologies Inc
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.
Fundamentals
| Revenue (TTM) | $158.32M |
| Gross Profit (TTM) | $145.08M |
| EBITDA | $-50.35M |
| Operating Margin | 21.50% |
| Return on Equity | -111.10% |
| Return on Assets | -11.50% |
| Revenue/Share (TTM) | $1.84 |
| Book Value | $0.51 |
| Price-to-Book | 74.14 |
| Price-to-Sales (TTM) | 20.79 |
| EV/Revenue | 21.0 |
| EV/EBITDA | -9.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 3055.00% |
| Shares Outstanding | $88.11M |
| Float | $61.37M |
| % Insiders | 13.40% |
| % Institutions | 71.10% |
Analyst Ratings
Consensus ($50.67 target)
1
Strong Buy7
Buy1
SellData last updated: 4/8/2026